Jarred M Lorusso

Mr. Jarred M Lorusso

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
RWRebecca Woods
Rebecca Woods
JLJarred M Lorusso
Jarred M Lorusso
HPHarry G. Potter
Harry G. Potter
JNJoanna C. Neill
Joanna C. Neill
JGJocelyn D. Glazier
Jocelyn D. Glazier
RHReinmar Hager
Reinmar Hager
Maternal immune activation (mIA) during pregnancy is hypothesised to disrupt offspring neurodevelopment and predispose offspring to neurodevelopmental disorders such as schizophrenia. Rodent models of mIA have explored possible mechanisms underlying this paradigm and provide a vital tool for preclinical research. However, a comprehensive analysis of the molecular changes that occur in mIA-models is lacking, hindering identification of robust clinical targets. This systematic review assesses mIA-driven transcriptomic and epigenomic alterations in specific offspring brain regions. Across 118 studies, we focus on 88 candidate genes and show replicated changes in expression in critical functional areas, including elevated inflammatory markers, and reduced myelin and GABAergic signalling proteins. Further, disturbed epigenetic markers at nine of these genes support mIA-driven epigenetic modulation of transcription. Overall, our results demonstrate that current outcome measures have direct relevance for the hypothesised pathology of schizophrenia and emphasise the importance of mIA-models in contributing to the understanding of biological pathways impacted by mIA and the discovery of new drug targets.

20 September 2022 in Brain, Behavior, & Immunity - Health
Verified
Journal Article
Open access
JLJarred M Lorusso
Jarred M Lorusso
RWRebecca M. Woods
Rebecca M. Woods
FMFrancesca McEwan
Francesca McEwan
JGJocelyn D. Glazier
Jocelyn D. Glazier
JNJoanna C. Neill
Joanna C. Neill
RHReinmar Hager
Reinmar Hager
Schizophrenia and other neurodevelopmental disorders often have very heterogeneous symptoms, especially regarding cognition: while some individuals may exhibit deficient cognition, others are relatively unaffected. Studies using developmental animal models often ignore phenotypic heterogeneity in favour of traditional treatment/control comparisons. This may result in resilient or unaffected individuals masking the effects of susceptible individuals if grouped together. Here, we used maternal immune activation and limited bedding and nesting, respectively, as a two-hit neurodevelopmental model for schizophrenia. Both factors reduced cognitive function in a novel object recognition (NOR) task. While we found treatment group effects on cognitive phenotypes, behavioural clustering identified three subpopulations exposed to either insult: those exhibiting ‘typical’ cognitive performance on the NOR, an intermediate phenotype, or a marked deficit. These clusters included offspring from each treatment group, although both intermediate and marked deficit clusters were composed primarily of offspring from treated groups. Clustering allowed stratification within treatment groups into ‘susceptible’ and ‘resilient’ individuals, while also identifying conserved phenotypes across treatment groups. Using unbiased cluster analyses in preclinical models can better characterize phenotypes and enables a better understanding of both face and construct validity of phenotypic heterogeneity. The use of unbiased clustering techniques may help identify potential markers associated with individual susceptibility and resilience in neurodevelopmental disorder models.

26 May 2025 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
FMFrancesca McEwan
Francesca McEwan
CKChiho Kambara
Chiho Kambara
JLJarred M Lorusso
Jarred M Lorusso
MHMichael K. Harte
Michael K. Harte
JGJocelyn D. Glazier
Jocelyn D. Glazier
RHReinmar Hager
Reinmar Hager
Exposure to maternal immune activation (MIA) in utero is a major risk factor for neurodevelopmental disorders, including schizophrenia. However, a proportion of individuals are resilient to developing schizophrenia following exposure to MIA, which has also been reported in animal models of MIA. The molecular mechanisms leading to resilient and vulnerable behavioural phenotypes remain poorly understood, and we currently lack reliable blood biomarkers that predict resilience or vulnerability. Redox dysregulation, caused by an imbalance between oxidative stress and antioxidant defence mechanisms, has recently been predicted to be central to the pathogenesis of schizophrenia. Here, we use a poly(I:C)-induced MIA model of schizophrenia to investigate mechanisms underlying cognitive dysfunction and redox dysregulation in resilient and vulnerable individuals. We show that activity of the antioxidant enzyme superoxide dismutase (SOD) was reduced in the plasma of poly(I:C) offspring with a cognitive deficit, in contrast to individuals with typical cognition during both adolescence and adulthood. However, SOD activity in the hippocampus was not significantly different between vulnerable and resilient offspring. In addition, the lipid peroxidation marker malondialdehyde (MDA) and the pro-inflammatory cytokine IL-6 were not differentially expressed within the hippocampus or plasma of vulnerable poly(I:C) offspring. Our results suggest that reduced plasma SOD activity may be a potential blood biomarker to identify resilience or vulnerability to MIA-induced cognitive deficits. Further research is necessary to determine if reduced antioxidant capacity is present in plasma prior to symptom presentation and to understand if this predicts redox dysregulation in the brain.

11 May 2026 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
JLJarred M Lorusso
Jarred M Lorusso
RHReinmar Hager
Reinmar Hager
Maternal effects are the most important aspect of the early environment and influence the physiology, development and behaviour of offspring. Maternal effects result in both between-litter variation (VarB), where litters reared by different dams exhibit marked differences in outcomes, and within-litter variation (VarW), where differences between pups of the same litters results in outcome heterogeneity. In addition to this maternally-caused between and within-litter variability in outcomes measures, experimental procedures can give rise to VarB and VarW through pre- and postnatal manipulations. Unless sufficiently and appropriately mitigated, experimental outcomes can be misinterpreted. Approaches to mitigating VarB, such as the use of single offspring within a litter, often overlooks VarW and can result in erroneous conclusions through sampling error. In contrast, approaches that aim to account for VarW, such as analysing offspring as independent samples, could result in VarB being overlooked. Recently, the use of random models in statistical analysis, whereby dam is considered a random source of variation and offspring a pseudo-replication, can afford insight into both sources of variation. We provide an example of these sources of variation through maternal immune activation (MIA), commonly used as a preclinical model of neurodevelopmental disorders. MIA involves inducing gestational inflammation, resulting in VarB from the dam-specific immune response, and VarW from the differential response within the litter from factors such as intrauterine position. In this review, we identify key sources of variation between and within litters and suggest considerations for how to deal with VarB and VarW in designing experiments and data analysis.